Wuhan Wansheng Biotechnology: difference between revisions
Diff·revision 34 → 35·00:33, 19 Jan 2025
Difference between revision 34 and revision 35 of Wuhan Wansheng Biotechnology. 1 line changed; the page grew by 92 bytes.
| Revision 34 — 04:32, 9 Jan 2025 BlankVialBo (talk) convert list to prose 7,423 bytes ±0 | Revision 35 — 00:33, 19 Jan 2025 Chromatokid (talk) add figure 7,515 bytes +92 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=RfC: does a large report set support any conclusion?}} | |
| 21 | 22 | ||
| 22 | '''Wuhan Wansheng Biotechnology Co., Ltd.''' (trading as '''WWB'''; wuhanwanshengbio.com) is a research-compound supplier based in Wuhan, Hubei, China, supplying research peptides, SARMs and raw materials, and notable for having one of the largest published third-party test-report sets of any organisation covered on this wiki.{{r|registry,selfpub}} | 23 | '''Wuhan Wansheng Biotechnology Co., Ltd.''' (trading as '''WWB'''; wuhanwanshengbio.com) is a research-compound supplier based in Wuhan, Hubei, China, supplying research peptides, SARMs and raw materials, and notable for having one of the largest published third-party test-report sets of any organisation covered on this wiki.{{r|registry,selfpub}} |